Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2016 8:32:32 GMT -5
I hate to say it but I don't think RLS is some body big or even real for that matter. They are partnered with MNKD and with MNKD needing money having a legit company working with them would have helped in negotiations with other partners or better terms for the offering. No one on the street believes in those 100 million in mile stones.
|
|
|
Post by sportsrancho on May 11, 2016 8:45:57 GMT -5
You are right the street does not believe it. This is what is so much fun:-)))
|
|
|
Post by uvula on May 11, 2016 8:48:09 GMT -5
If RLS is not real this would amount to fraud and possible criminal charges. I doubt Sr management would take that risk. Eventually the truth will come out.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2016 9:04:06 GMT -5
please dont be naive theres plenty of ways to make a shell without committing fraud
|
|
|
Post by peppy on May 11, 2016 9:11:48 GMT -5
I hate to say it but I don't think RLS is some body big or even real for that matter. They are partnered with MNKD and with MNKD needing money having a legit company working with them would have helped in negotiations with other partners or better terms for the offering. No one on the street believes in those 100 million in mile stones. I know you know what is going on in the world of Cannabis. it is real. do not let MNKD share price screw with your brain.
The corruption in pharma is down to the core, shielded by words like proof. Most of the mechanism of action on FDA approved pharma meds that I read is unknown.
What if cannabis really does cure cancer and Tricky Dick Nixon out lawed it to keep the population down and the government coffers filled? Reagan (movie star not knowing better) went for the story. Just say no and upped all criminal penalties. Then the corruption of run for the cure.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2016 9:29:13 GMT -5
I hate to say it but I don't think RLS is some body big or even real for that matter. They are partnered with MNKD and with MNKD needing money having a legit company working with them would have helped in negotiations with other partners or better terms for the offering. No one on the street believes in those 100 million in mile stones. I know you know what is going on in the world of Cannabis. it is real. do not let MNKD share price screw with your brain.
The corruption in pharma is down to the core, shielded by words like proof. Most of the mechanism of action on FDA approved pharma meds that I read is unknown.
What if cannabis really does cure cancer and Tricky Dick Nixon out lawed it to keep the population down and the government coffers filled? Reagan (movie star not knowing better) went for the story. Just say no and upped all criminal penalties. Then the corruption of run for the cure.
I try to be objective and think things through. I def know a lot about pot lol I know how corrupt the Pharmacy industry is or the world in general for that matter. As I have mentioned so many times I would love for them to be involved with Cannabis. I look at it this way and please tell me if the way I am thinking is irrational. Right now MNKD is battling to survive. RLS should want to see MNKD survive because of their partnership. Why are they hiding especially when MNKD cause use the stability of their relationship as leverage in negotiations. IF MNKD goes down so does RLS ability to use Technospehre for whatever they plan to use it for. We fall, and they fall. If they are offering a 100 million in mile stones they must see some serious potential in technospehre. You dont hide from your allies on the battle field if you have a vested interest.
|
|
|
Post by peppy on May 11, 2016 9:39:03 GMT -5
I know you know what is going on in the world of Cannabis. it is real. do not let MNKD share price screw with your brain.
The corruption in pharma is down to the core, shielded by words like proof. Most of the mechanism of action on FDA approved pharma meds that I read is unknown.
What if cannabis really does cure cancer and Tricky Dick Nixon out lawed it to keep the population down and the government coffers filled? Reagan (movie star not knowing better) went for the story. Just say no and upped all criminal penalties. Then the corruption of run for the cure.
I try to be objective and think things through. I def know a lot about pot lol I know how corrupt the Pharmacy industry is or the world in general for that matter. As I have mentioned so many times I would love for them to be involved with Cannabis. I look at it this way and please tell me if the way I am thinking is irrational. Right now MNKD is battling to survive. RLS should want to see MNKD survive because of their partnership. Why are they hiding especially when MNKD cause use the stability of their relationship as leverage in negotiations. IF MNKD goes down so does RLS ability to use Technospehre for whatever they plan to use it for. We fall, and they fall. If they are offering a 100 million in mile stones they must see some serious potential in technospehre. You dont hide from your allies on the battle field if you have a vested interest. Quote: Why are they hiding You know the answer to that also. We all know the answer to that. Prison and everything you own taken away for growing a plant. weehaw. Thanks Ronald and Nancy. Consider our government in the day of no information brain washed us all. The government used to tell us the USSR brainwashed their people. It may have been our government doing the brain washing?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2016 10:03:27 GMT -5
So you are saying RLS is staying behind the scenes because they are afraid of being arressted if assoicated with pot?
|
|
|
Post by peppy on May 11, 2016 10:06:13 GMT -5
So you are saying RLS is staying behind the scenes because they are afraid of being arressted if assoicated with pot? No. I believe it has more to do with the federal/ state laws and differences that need to be ironed out. What do you think?
The other stuff was just a crap count.
|
|
|
Post by tripoley on May 11, 2016 10:13:25 GMT -5
please dont be naive theres plenty of ways to make a shell without committing fraud The fraud would relate to info provided to MNKD shareholders about RLS, not about RLS itself. Seriously doubt MNKD would do that.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2016 10:32:20 GMT -5
So you are saying RLS is staying behind the scenes because they are afraid of being arressted if assoicated with pot? No. I believe it has more to do with the federal/ state laws and differences that need to be ironed out. What do you think?
The other stuff was just a crap count.
I dont know what to think tbh
|
|
|
Post by prosper on May 11, 2016 10:48:30 GMT -5
I think almost all of you here have already engineered and are using cannabis loaded technosphere.
|
|
|
Post by lakers on May 16, 2016 19:33:54 GMT -5
Omeros' (OMER) CEO Greg Demopulos on Q1 2016 Results - Earnings Call Transcript May 11, 2016 7:00 PM ET seekingalpha.com/article/3974285-omeros-omer-ceo-greg-demopulos-q1-2016-results-earnings-call-transcript?part=singleFinally, our GPCR program is making substantial strides. We’re advancing preclinical programs targeting appetite and eating disorders, triple negative breast cancer, demyelinating diseases such as multiple sclerosis, neuropathic pain and osteoporosis as well as the receptor that appears to modulate T-cell regulation important in immunologic disorders and cancer. Compounds across these programs have been optimized sufficiently to conduct animal studies and data have been generated. That concludes our update on Omeros’ products and programs. Greg Demopulos Yes. I mean I think that we’ll be putting out 721 data as you said from our Phase II program or programs. There will be publications on both 721 and 527. I think there will be more data coming out of the GPCR program. So I think that there’s going to be a long line of data and journal articles publications throughout the year. www.veracast.com/webcasts/baml/healthcare2016/events/3012_mannki/pdf/MannKind_Corp.pdfDemonstrate License Model for Technosphere – First Technosphere® licensing deal complete with Receptor Life Sciences (Jan) • Highly credible backers
• Under NDA • $250k signing • 1 st milestone later in year
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 16, 2016 19:45:20 GMT -5
Omeros' (OMER) CEO Greg Demopulos on Q1 2016 Results - Earnings Call Transcript May 11, 2016 7:00 PM ET seekingalpha.com/article/3974285-omeros-omer-ceo-greg-demopulos-q1-2016-results-earnings-call-transcript?part=singleFinally, our GPCR program is making substantial strides. We’re advancing preclinical programs targeting appetite and eating disorders, triple negative breast cancer, demyelinating diseases such as multiple sclerosis, neuropathic pain and osteoporosis as well as the receptor that appears to modulate T-cell regulation important in immunologic disorders and cancer. Compounds across these programs have been optimized sufficiently to conduct animal studies and data have been generated. That concludes our update on Omeros’ products and programs. Greg Demopulos Yes. I mean I think that we’ll be putting out 721 data as you said from our Phase II program or programs. There will be publications on both 721 and 527. I think there will be more data coming out of the GPCR program. So I think that there’s going to be a long line of data and journal articles publications throughout the year. www.veracast.com/webcasts/baml/healthcare2016/events/3012_mannki/pdf/MannKind_Corp.pdfDemonstrate License Model for Technosphere – First Technosphere® licensing deal complete with Receptor Life Sciences (Jan) • Highly credible backers
• Under NDA • $250k signing • 1 st milestone later in year adding gpcr link www.omeros.com/pipeline/gpcr.htm
|
|
|
Post by peppy on May 16, 2016 21:43:12 GMT -5
Omeros' (OMER) CEO Greg Demopulos on Q1 2016 Results - Earnings Call Transcript May 11, 2016 7:00 PM ET seekingalpha.com/article/3974285-omeros-omer-ceo-greg-demopulos-q1-2016-results-earnings-call-transcript?part=singleFinally, our GPCR program is making substantial strides. We’re advancing preclinical programs targeting appetite and eating disorders, triple negative breast cancer, demyelinating diseases such as multiple sclerosis, neuropathic pain and osteoporosis as well as the receptor that appears to modulate T-cell regulation important in immunologic disorders and cancer. Compounds across these programs have been optimized sufficiently to conduct animal studies and data have been generated. That concludes our update on Omeros’ products and programs. Greg Demopulos Yes. I mean I think that we’ll be putting out 721 data as you said from our Phase II program or programs. There will be publications on both 721 and 527. I think there will be more data coming out of the GPCR program. So I think that there’s going to be a long line of data and journal articles publications throughout the year. www.veracast.com/webcasts/baml/healthcare2016/events/3012_mannki/pdf/MannKind_Corp.pdfDemonstrate License Model for Technosphere – First Technosphere® licensing deal complete with Receptor Life Sciences (Jan) • Highly credible backers
• Under NDA • $250k signing • 1 st milestone later in year adding gpcr link www.omeros.com/pipeline/gpcr.htm with What makes you think Omeros is going to hit the protein coupled receptors delineated with: (?) IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for human use; inhalers sold pre-filled with pharmaceutical preparations; plant extracts for pharmaceutical purposes
IC 042. US 100 101. G & S: scientific and medical research relating to the diagnosis and treatment of medical conditions; scientific and medical research relating to plant extracts for pharmaceutical purposes
IC 044. US 100 101. G & S: providing a website featuring information relating to the diagnosis and treatment of medical conditions
Though not definitive, this is support for claims that the API is some sort of cannabis extract.
Omeros Our most advanced product candidates are derived from our proprietary PharmacoSurgery® platform designed to improve clinical outcomes of patients undergoing ophthalmological, arthroscopic, urological and other surgical and medical procedures. Our PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to inhibit preemptively inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery. www.omeros.com/about/about.htm
|
|